6 results
424B3
WGS
GeneDx Holdings Corp - Ordinary Shares
11 May 22
Prospectus supplement
5:06pm
appointments and services.
As discussed above, we no longer report the number of accessioned tests as a key performance indicator because the number
424B3
WGS
GeneDx Holdings Corp - Ordinary Shares
28 Mar 22
Prospectus supplement
5:15pm
and services.
As discussed above, we no longer report the number of accessioned tests as a key performance indicator because the number of resulted tests
POS AM
WGS
GeneDx Holdings Corp - Ordinary Shares
21 Mar 22
Prospectus update (post-effective amendment)
5:19pm
performance indicator because the number of resulted tests more directly correlates with long-term patient relationships and the size of our genomic … and clinics, had suspended non-emergency appointments and services.
As discussed above, we no longer report the number of accessioned tests as a key
424B3
WGS
GeneDx Holdings Corp - Ordinary Shares
14 Mar 22
Prospectus supplement
5:23pm
of accessioned tests as a key performance indicator because the number of resulted tests more directly correlates with long-term patient relationships
- Prev
- 1
- Next